louisiana glp-1 intestinal paralysis law firm As drugs continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: "Ozempic feet." link in bio 🔗 Rybelsus Lawsuit - Shreveport Lawyer

Not at a 45

13.5% of participants in the semaglutide group discontinued their treatment due to side effects, compared to 27.6% with liraglutide

But in the beginning of last year, we, we said, no, it has to be for a diabetes prescription. -Senior Human Resources Leader, large services organization The use of GLP-1 agonists was higher than expected for many large employers including for over half (59%) of employers over 5,000 workers Since then, many larger employers covering GLP-1 agonists for weight loss reported higher than expected use of the medications and significant impacts on their prescription spending

Woodward, P